TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

Document text

Principal Investigator: Laura Pilar Gelfman
Organization: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Fiscal Year: 2024
Award: $167,035
Funding agency: National Institute of Nursing Research

ABSTRACT
Persons with serious illness suffer from poor symptom control, decreased quality of life (QoL) and poor
communication with their healthcare providers, especially in terms of goals of care discussions (GOCD).
Palliative care, when offered alongside disease management, offers improved symptom control, QoL,
communication, caregiver satisfaction and reduced caregiver anxiety. Due to a limited specialty-trained
palliative care workforce, however, patients and their caregivers often cannot access these benefits, especially
in the community. These needs are particularly acute in advanced cancer and HF, the two leading causes of
death in the US which also model the most common illness trajectories. The dynamic nature of these illnesses
presents distinct symptom patterns and changing functional status that require an adaptive, dynamic model of
palliative care delivery. Yet, workforce shortages prevent scaling of existing community-based specialty
palliative care models. To meet patient/caregiver dyads' needs with a limited workforce, new models that
deploy palliative care clinicians based on patient's illness trajectory and changing needs are required. The
innovative TIER-PALLIATIVE CARE (TIER-PC) model provides the right level of care to the right patients at the
right time. TIER-PC increases the number and intensity of specialty trained palliative care disciplines added to
the dyad's care team as their symptoms worsen and function declines. In Tier 1, patients who can care for
themselves and have easily managed symptoms, receive support from a community health worker (CHW)
trained to elicit illness understanding in a culturally competent way. In Tier 2, for patients with poorer function
and mild symptoms, a social worker (SW), trained in serious illness communication, joins the CHW to further
elicit patients' illness understanding and goals, and provide caregiver support. In Tier 3, as function decreases
and symptoms increase, an advance practice nurse (APN) joins the CHW+SW to manage complex symptoms.
In Tier 4, for those patients with the poorest function and worst symptoms, an MD joins to address the most
complex needs (e.g., end-of-life treatment preferences and multifaceted symptom control). The CHW follows
dyads longitudinally across all tiers and re-allocates them to the appropriate tier based on their evolving needs.
We will evaluate TIER-PC's efficacy in a multi-site, single blinded, two arm, randomized controlled trial. Patients
with advanced cancer or HF will receive regular assessments by the TIER-PC team to: address symptom and
psychosocial needs; improve illness/prognostic understanding; prescribe medications; and address goals of
care. We will enroll and randomize 400 patients with HF or cancer and their family caregivers to receive TIER-
PC or an augmented control. We will follow dyads for 12 months to determine if TIER-PC: improves patients'
symptom control and QoL (primary outcomes), patient-reported GOCDs and caregiver satisfaction; reduces
caregiver anxiety and post-traumatic stress; and decreases patients' healthcare utilization and cost. By
matching demand to the scarce workforce, our scalable model can improve care for patients with cancer or HF.

Terms: <2 arm RCT><2 arm randomized control trial><2 arm randomized controlled trial><APN><Accounting><Acute><Address><Advanced Cancer><Advanced Malignant Neoplasm><Advanced Practice Nurse><Anxiety><COVID-19><CV-19><Cancers><Care Givers><Care giver support><Caregiver support><Caregivers><Caring><Categories><Cause of Death><Cessation of life><Chaplain><Chaplaincy><Clinical><Communication><Communities><Community Health Aides><Community Trial><Complex><Coronavirus Infectious Disease 2019><Data><Death><Deterioration><Discipline><Disease><Disease Management><Disorder><Disorder Management><Drug Prescribing><Drug Prescriptions><ED visit><ER visit><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room visit><Enrollment><Ensure><Family Care Giver><Family Caregiver><Future><Generalized Growth><Goals><Growth><Health Care Costs><Health Care Providers><Health Care Utilization><Health Costs><Health Insurance for Aged and Disabled, Title 18><Health Insurance for Disabled Title 18><Health Personnel><Health system><Healthcare Costs><Healthcare Providers><Healthcare worker><Heart failure><Hospices><Hospital Admission><Hospitalization><Hospitals><Individual><Inpatients><Intervention><Intervention Strategies><Karnofsky><Karnofsky Index><Karnofsky Performance Status><Karnofsky Performance Status Scale><Karnofsky Scale><Length of Stay><Malignant Neoplasms><Malignant Tumor><Medicare><Modeling><Nature><Number of Days in Hospital><Outcome><Palliative Care><Palliative Therapy><Palliative Treatment><Patient Care><Patient Care Delivery><Patient Self-Report><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pattern><Persons><Physicians><Population><QOL><Quality of life><Randomization trial><Randomized><Recovery><Reporting><Research Resources><Resources><Self-Report><Service delivery model><Service model><Services><Single-Blind Study><Single-blind><Site><Social Workers><Specialty><Symptoms><Time><Tissue Growth><Title 18><Training><anxiety reduction><arm><cardiac failure><care costs><care delivery><care delivery model><care for patients><care of patients><care services><care systems><caring for patients><comfort care><community based care><community based service><community health worker><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><cost><cultural competence><culturally competent><decline in function><decline in functional status><determine efficacy><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><end of life><end-of-life><enroll><evaluate efficacy><examine efficacy><experience><functional decline><functional status><functional status decline><health care delivery model><health care personnel><health care service use><health care service utilization><health care worker><health insurance for disabled><health provider><health workforce><healthcare delivery model><healthcare personnel><healthcare service use><healthcare service utilization><healthcare utilization><hospice environment><hospital days><hospital length of stay><hospital stay><improve symptom><improved><innovate><innovation><innovative><interventional strategy><malignancy><manage symptom><medical personnel><medical specialties><medication prescription><member><neoplasm/cancer><novel><ontogeny><participant enrollment><patient enrollment><patient oriented outcomes><population based><post-trauma stress><post-traumatic stress><post-traumatic stress symptoms><post-traumatic symptoms><posttrauma stress><posttraumatic stress><posttraumatic stress symptoms><posttraumatic symptoms><preference><prescribed medication><prevent><preventing><primary outcome><prognostic><programs><psychosocial><randomisation><randomization><randomized trial><randomly assigned><satisfaction><symptom improvement><symptom management><symptomatic improvement><treatment provider><two arm RCT><two arm randomized control trial><two arm randomized controlled trial>